BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35755811)

  • 1. A Novel YTHDF3-Based Model to Predict Prognosis and Therapeutic Response in Breast Cancer.
    Liu J; Zhu J; Wang X; Zhou Z; Liu H; Zhu D
    Front Mol Biosci; 2022; 9():874532. PubMed ID: 35755811
    [No Abstract]   [Full Text] [Related]  

  • 2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.
    Lai J; Lin X; Cao F; Mok H; Chen B; Liao N
    J Cell Mol Med; 2021 Oct; 25(19):9390-9401. PubMed ID: 34464504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
    Hu Y; Fan S; Zhu Y; Xie X
    Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
    Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
    J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wen Q; Tan X; Chen Z; Liu G
    Dis Markers; 2019; 2019():5980567. PubMed ID: 31827637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
    Lai J; Chen B; Zhang G; Li X; Mok H; Liao N
    J Transl Med; 2020 Nov; 18(1):416. PubMed ID: 33160384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram based on CENPP expression for survival prediction in breast cancer.
    Chen H; Pu S; Yu S; Liao X; He J; Zhang H
    Gland Surg; 2021 Jun; 10(6):1874-1888. PubMed ID: 34268072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
    He M; Hu C; Deng J; Ji H; Tian W
    World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer.
    Yang X; Li J; Wang Y; Li P; Zhao Y; Duan W; Ariston Gabriel AN; Chen Y; Mao H; Wang Y; Du L; Wang C
    Front Oncol; 2020; 10():515421. PubMed ID: 33194577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy.
    Lai J; Wang H; Peng J; Chen P; Pan Z
    Cancer Manag Res; 2018; 10():2347-2356. PubMed ID: 30122984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms for prediction of overall and cancer-specific survival in young breast cancer.
    Sun Y; Li Y; Wu J; Tian H; Liu H; Fang Y; Li Y; Yu F
    Breast Cancer Res Treat; 2020 Nov; 184(2):597-613. PubMed ID: 32886273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():831848. PubMed ID: 35320931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
    Zhang Y; Chen Y; Chen R; Zhou H; Lin Y; Li B; Song H; Zhou G; Dong M; Xu H
    BMC Cancer; 2023 Sep; 23(1):882. PubMed ID: 37726690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Oxidative Stress-Related Genes Signature for Predicting Survival in Bladder Cancer: Based on TCGA Database and Bioinformatics.
    Zhang M; Du G; Li Z; Li D; Li W; Li H; Gao X; Tang Z
    Int J Gen Med; 2022; 15():2645-2667. PubMed ID: 35300137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
    Liang M; Chen M; Singh S; Singh S
    Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer.
    Sun X; Zhou ZR; Fang Y; Ding S; Lu S; Wang Z; Wang H; Chen X; Shen K
    Ann Transl Med; 2021 Mar; 9(5):367. PubMed ID: 33842588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
    Ping L; Zhang K; Ou X; Qiu X; Xiao X
    Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.